Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Travers

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Nature|April 9, 2010
Cancer: drug-tolerant insurgentsPaul Workman, Jon Travers
Drug Discovery Today|January 17, 2012
HSP90 inhibition: two-pronged exploitation of cancer dependenciesJon Travers, Swee Sharp, Paul Workman
Nature Chemical Biology|August 30, 2011
Epigenetics: Targeting leukemia on the DOTJon Travers, Julian Blagg, Paul Workman
Oncotarget|September 12, 2012
Shock about heat shock in cancerEmmanuel de Billy, Jon Travers, Paul Workman
Molecular Cancer Therapeutics|December 28, 2018
TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <i>In Vitro</i> and <i>In Vivo</i>Srimoyee Ghosh, Geeta Sharma, Jon Travers, et al.
Elife|December 14, 2018
Structured illumination microscopy combined with machine learning enables the high throughput analysis and classification of virus structureRomain F Laine, Gemma Goodfellow, Laurence J Young, et al.
Nature Communications|March 26, 2021
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugsHenry Gerdes, Pedro Casado, Arran Dokal, et al.
Science (New York, N.Y.)|January 10, 2015
DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repairTakashi Ochi, Andrew N Blackford, Julia Coates, et al.
Plos One|October 28, 2015
Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's SarcomaSonja J Gill, Jon Travers, Irina Pshenichnaya, et al.
Cell Death & Disease|November 9, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibitionShivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Nature|April 9, 2010
Cancer: drug-tolerant insurgentsPaul Workman, Jon Travers
Drug Discovery Today|January 17, 2012
HSP90 inhibition: two-pronged exploitation of cancer dependenciesJon Travers, Swee Sharp, Paul Workman
Nature Chemical Biology|August 30, 2011
Epigenetics: Targeting leukemia on the DOTJon Travers, Julian Blagg, Paul Workman
Oncotarget|September 12, 2012
Shock about heat shock in cancerEmmanuel de Billy, Jon Travers, Paul Workman
Molecular Cancer Therapeutics|December 28, 2018
TSR-033, a Novel Therapeutic Antibody Targeting LAG-3, Enhances T-Cell Function and the Activity of PD-1 Blockade <i>In Vitro</i> and <i>In Vivo</i>Srimoyee Ghosh, Geeta Sharma, Jon Travers, et al.
Elife|December 14, 2018
Structured illumination microscopy combined with machine learning enables the high throughput analysis and classification of virus structureRomain F Laine, Gemma Goodfellow, Laurence J Young, et al.
Nature Communications|March 26, 2021
Drug ranking using machine learning systematically predicts the efficacy of anti-cancer drugsHenry Gerdes, Pedro Casado, Arran Dokal, et al.
Science (New York, N.Y.)|January 10, 2015
DNA repair. PAXX, a paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repairTakashi Ochi, Andrew N Blackford, Julia Coates, et al.
Plos One|October 28, 2015
Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's SarcomaSonja J Gill, Jon Travers, Irina Pshenichnaya, et al.
Cell Death & Disease|November 9, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibitionShivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar, et al.
Pageof 2